immunoadsorption

  1. G

    Drug study with Efgartigimod for POTS

    Interesting study being planned for POTS with Efgartigimod. A monoclonal antibody fragment that binds other antibodies. Think of it like a pharmaceutical immunoadsorption without the extracorporeal circuit. More info on the drug here ⬇️ https://www.argenx.com/pipeline/efgartigimod More info...

Support Our Work

Health Rising’s Quickie 2025 Summer Donation Drive Has Begun!

HEALTH RISING IS NOT A 501 (c) 3 NON-PROFIT

Get Our Free ME/CFS and FM Blog!

Forum Tips

Shopping on Amazon.com For HR

Latest Resources

Top